5-methoxy-alpha-methyltryptamine has been researched along with Glaucoma, Suspect in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, HH; Lynch, VM; May, JA; McLaughlin, MA; Rusinko, A; Sharif, NA | 1 |
Dantanarayana, AP; May, JA; McLaughlin, MA; Sharif, NA; Zinke, PW | 1 |
2 other study(ies) available for 5-methoxy-alpha-methyltryptamine and Glaucoma, Suspect
Article | Year |
---|---|
A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Blood Pressure; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Indoles; Inhibitory Concentration 50; Macaca fascicularis; Models, Molecular; Ocular Hypertension; Radioligand Assay; Rats; Receptors, Adrenergic; Receptors, Serotonin; Recombinant Proteins; Serotonin Receptor Agonists; Stereoisomerism | 2003 |
1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Haplorhini; Head Movements; Humans; Indazoles; Lasers; Mice; Molecular Structure; Ocular Hypertension; Rabbits; Rats; Serotonin 5-HT2 Receptor Agonists | 2006 |